Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510068
Status:
COMPLETED
Last Update Posted:
2015-07-01
First Post:
2007-07-31
Brief Title:
Efficacy and Safety of Everolimus RAD001 Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis